GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Net Change in Cash

Senseonics Holdings (Senseonics Holdings) Net Change in Cash : $45.78 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Senseonics Holdings Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Senseonics Holdings's Net Change in Cash for the three months ended in Mar. 2024 was $15.15 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was $45.78 Mil.

Senseonics Holdings Net Change in Cash Historical Data

The historical data trend for Senseonics Holdings's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Senseonics Holdings Net Change in Cash Chart

Senseonics Holdings Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.86 -77.73 15.26 2.33 39.92

Senseonics Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.29 -16.53 27.21 19.95 15.15

Senseonics Holdings Net Change in Cash Calculation

Senseonics Holdings's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-70.163+89.713+20.366+0
=39.92

Senseonics Holdings's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-20.262+25.379+10.034+0
=15.15

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $45.78 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Senseonics Holdings Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Senseonics Holdings's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Senseonics Holdings (Senseonics Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Senseonics Holdings Inc (AMEX:SENS) » Definitions » Net Change in Cash
Comparable Companies
TCMD ARAY CVRX RCEL CERS NNOX SILK BVS ALUR LUNG ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
6L6:Germany 6L6:Germany
Address
20451 Seneca Meadows Parkway, Germantown, MD, USA, 20876-7005
Website
https://www.senseonics.com
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of the glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Executives
Sharon Larkin director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Douglas A Roeder director 160 BOVET RD, SUITE 408, C/O DELPHI VENTURES, SAN MATEO CA 94402
Frederick T. Sullivan officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Mukul Jain officer: VP Operations, Qual & Reg 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Edward Fiorentino director 1350 KENNICOTT DRIVE, LAKE FOREST IL 60045
Mirasol Panlilio officer: VP Global Sales & Marketing 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Timothy T Goodnow director, officer: President & Chief Exec Officer 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Francine Kaufman officer: Chief Medical Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Kenneth L Horton officer: GC & Corp. Development Advisor VERTEX PHARMACEUTICALS INCORPORATED, 130 WAVERLY STREET, CAMBRIDGE MA 02139
Nick B. Tressler officer: Chief Financial Officer C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 208786
Anthony R. Raab director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
John Marotta director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876
Stephen P Defalco director ONE EXETER STREET, BOSTON MA 02116
Douglas S Prince director 20 TILESTON STREET, PH4, BOSTON MA 02113
Edelman Steven director C/O SENSEONICS HOLDINGS, INC., 20451 SENECA MEADOWS PARKWAY, GERMANTOWN MD 20876

Senseonics Holdings (Senseonics Holdings) Headlines

From GuruFocus

Thinking about buying stock in Iterum Therapeutics, Kymera Therapeutics, Senseonics, Avrobio, or ChemoCentryx?

By PRNewswire PRNewswire • 06-28-2021

Thinking about buying stock in Nextplay Technologies, Sio Gene Therapies, Kadmon, Senseonics, or InMed Pharmaceuticals?

By PRNewswire PRNewswire • 10-21-2021

Thinking about buying stock in Moneygram, Kaival Brands, Senseonics, BP, or Cinedigm?

By PRNewswire PRNewswire • 02-15-2022

Thinking about buying stock in Longeveron, Senseonics, Connect Biopharma, Wejo Group, or Energous Corp?

By PRNewswire PRNewswire • 01-05-2022

Thinking about buying stock in TAL Education, Newegg, Meta Materials, Zomedica, or Senseonics?

By PRNewswire PRNewswire • 08-30-2021

Thinking about buying stock in Barclays, Norwegian Cruise Line, Senseonics, W&T Offshore, or Transocean?

By PRNewswire PRNewswire • 03-05-2021

Newbridge Financial Services Group, Inc. Buys Senseonics Holdings Inc, Boeing Co, Alibaba Group Holding, Sells John Hancock Premium Div Fund, Blackrock Duration Income Trust, Calamos Convertible & High Income Fund

By GuruFocus Research GuruFocus Editor • 10-27-2021

Thinking about buying stock in Exicure, Yellow Corp, Senseonics, Global Blood Therapeutics, or Motus GI?

By PRNewswire PRNewswire • 08-04-2022

Thinking about buying stock in 360 DigiTech, CohBar, Buckle, Amyris, or Senseonics?

By PRNewswire PRNewswire • 08-20-2021

Thinking about buying stock in Spirit Airlines, Bitfarms, HIVE Blockchain, Bit Digital, or Senseonics?

By PRNewswire PRNewswire • 02-07-2022